JFS WEALTH ADVISORS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 245 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
JFS WEALTH ADVISORS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$3,227
-3.1%
390.0%0.00%
Q1 2024$3,329
-0.2%
390.0%0.00%
Q4 2023$3,335
-4.6%
390.0%0.00%
Q3 2023$3,494
+2.6%
39
-2.5%
0.00%
Q2 2023$3,406
+2.9%
400.0%0.00%
Q1 2023$3,310
-14.1%
40
-18.4%
0.00%
Q4 2022$3,854
+28.5%
49
+4.3%
0.00%
Q3 2022$3,0000.0%47
-4.1%
0.00%
Q2 2022$3,000
+50.0%
49
+88.5%
0.00%
Q1 2022$2,000
+100.0%
26
+116.7%
0.00%
Q4 2021$1,000120.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders